Dentons Link Legal has acted as legal counsel to Kashiv BioSciences Private Limited (“Kashiv”) and its’ promoters, on availing financial assistance of INR 648 Crores from Union Bank of India to expand its state-of-the-art manufacturing facility in Pipan, near Ahmedabad, Gujarat. The new single-use commercial manufacturing facility will be one of India’s largest, equipped with cutting-edge technologies to support the production of high-quality biologics and specialty pharmaceuticals. At full capacity, Kashiv expects the facility to manufacture up to 50,000 liters.
This infrastructure is being financed with the support of the Union Bank of India and is in alignment with the biotechnology policy and schemes implemented by GSBTM (Gujarat State Biotechnology Mission), a body of the state government. Kashiv is a wholly owned subsidiary of Kashiv BioSciences, LLC (USA) which is among the few companies to both manufacture and receive marketing authorization for multiple biosimilars.
Dentons Link Legal advised Kashiv and the promoter group in structuring of the entire transaction, on the documentation and certain foreign exchange related aspects.
The Dentons Link Legal team comprised of Madhur Verma (Partner) supported by Kavan Patel (Associate).
The deal has been widely published on the following:
- Kashiv BioSciences Secures INR 648 Crore Financing from Union Bank of India to Expand Manufacturing Facilities in Gujarat, India
- Articles published by Kashiv BioSciences Private Limited
- Kashiv BioSciences Secures INR 648 Crore Financing from Union Bank of India to Expand Manufacturing Facilities in Gujarat, India